Abstract
Tuberculosis remains an emergent problem of public health. Over the years, the mycobacteria have acquired mutations able to modify their virulence and/or resistance to chemotherapy. In previous studies, we published that in contrast to the most common laboratory Mycobacterium tuberculosis (Mtb) complex isolates, hypervirulent isolates display a unique ability to modulate the immune respon…